nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—Diphenhydramine—atopic dermatitis	0.384	1	CrCtD
Imipramine—Bromodiphenhydramine—Dimenhydrinate—atopic dermatitis	0.0254	0.102	CrCrCtD
Imipramine—ORM1—Tacrolimus—atopic dermatitis	0.0239	0.0867	CbGbCtD
Imipramine—CYP2C18—Diphenhydramine—atopic dermatitis	0.0237	0.0861	CbGbCtD
Imipramine—CHRM2—Dimenhydrinate—atopic dermatitis	0.0204	0.0739	CbGbCtD
Imipramine—Orphenadrine—Dimenhydrinate—atopic dermatitis	0.0199	0.0801	CrCrCtD
Imipramine—HRH1—Dimenhydrinate—atopic dermatitis	0.0186	0.0675	CbGbCtD
Imipramine—Diphenhydramine—Dimenhydrinate—atopic dermatitis	0.0177	0.0711	CrCrCtD
Imipramine—Doxepin—Diphenhydramine—atopic dermatitis	0.0165	0.0662	CrCrCtD
Imipramine—Cyclobenzaprine—Diphenhydramine—atopic dermatitis	0.0155	0.0622	CrCrCtD
Imipramine—KCNH2—Loratadine—atopic dermatitis	0.0154	0.0559	CbGbCtD
Imipramine—Dimetindene—Diphenhydramine—atopic dermatitis	0.015	0.0605	CrCrCtD
Imipramine—SLC22A2—Diphenhydramine—atopic dermatitis	0.0145	0.0525	CbGbCtD
Imipramine—Doxylamine—Diphenhydramine—atopic dermatitis	0.0142	0.0572	CrCrCtD
Imipramine—Amitriptyline—Diphenhydramine—atopic dermatitis	0.0139	0.0557	CrCrCtD
Imipramine—Tripelennamine—Diphenhydramine—atopic dermatitis	0.0129	0.0518	CrCrCtD
Imipramine—Trimipramine—Diphenhydramine—atopic dermatitis	0.0126	0.0506	CrCrCtD
Imipramine—SLC22A1—Diphenhydramine—atopic dermatitis	0.0126	0.0456	CbGbCtD
Imipramine—Bromodiphenhydramine—Diphenhydramine—atopic dermatitis	0.012	0.0484	CrCrCtD
Imipramine—Dimetacrine—Diphenhydramine—atopic dermatitis	0.012	0.0484	CrCrCtD
Imipramine—Pheniramine—Diphenhydramine—atopic dermatitis	0.0118	0.0474	CrCrCtD
Imipramine—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0108	0.0391	CbGbCtD
Imipramine—CYP3A7—Tacrolimus—atopic dermatitis	0.0108	0.0391	CbGbCtD
Imipramine—Promethazine—Diphenhydramine—atopic dermatitis	0.0107	0.0429	CrCrCtD
Imipramine—Alimemazine—Diphenhydramine—atopic dermatitis	0.0105	0.0421	CrCrCtD
Imipramine—CHRM2—Diphenhydramine—atopic dermatitis	0.00996	0.0361	CbGbCtD
Imipramine—Clofedanol—Diphenhydramine—atopic dermatitis	0.00977	0.0393	CrCrCtD
Imipramine—Orphenadrine—Diphenhydramine—atopic dermatitis	0.00946	0.038	CrCrCtD
Imipramine—HRH1—Loratadine—atopic dermatitis	0.00909	0.0329	CbGbCtD
Imipramine—HRH1—Diphenhydramine—atopic dermatitis	0.00909	0.0329	CbGbCtD
Imipramine—Promazine—Diphenhydramine—atopic dermatitis	0.00903	0.0363	CrCrCtD
Imipramine—CYP2B6—Diphenhydramine—atopic dermatitis	0.00751	0.0272	CbGbCtD
Imipramine—CYP3A4—Pimecrolimus—atopic dermatitis	0.0053	0.0192	CbGbCtD
Imipramine—ABCB1—Tacrolimus—atopic dermatitis	0.00526	0.0191	CbGbCtD
Imipramine—CYP2C19—Loratadine—atopic dermatitis	0.00477	0.0173	CbGbCtD
Imipramine—CYP2C19—Diphenhydramine—atopic dermatitis	0.00477	0.0173	CbGbCtD
Imipramine—CYP1A2—Diphenhydramine—atopic dermatitis	0.0044	0.016	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.00439	0.0159	CbGbCtD
Imipramine—CYP3A7—Hydrocortisone—atopic dermatitis	0.00439	0.0159	CbGbCtD
Imipramine—ABCB1—Loratadine—atopic dermatitis	0.00385	0.014	CbGbCtD
Imipramine—CYP2D6—Loratadine—atopic dermatitis	0.00363	0.0132	CbGbCtD
Imipramine—CYP2D6—Diphenhydramine—atopic dermatitis	0.00363	0.0132	CbGbCtD
Imipramine—ABCB1—Methylprednisolone—atopic dermatitis	0.00352	0.0128	CbGbCtD
Imipramine—CYP3A4—Tacrolimus—atopic dermatitis	0.00315	0.0114	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.00273	0.00989	CbGbCtD
Imipramine—CYP3A7—Dexamethasone—atopic dermatitis	0.00273	0.00989	CbGbCtD
Imipramine—CYP2C19—Prednisone—atopic dermatitis	0.00265	0.00959	CbGbCtD
Imipramine—CYP2E1—Dexamethasone—atopic dermatitis	0.00263	0.00955	CbGbCtD
Imipramine—CYP2B6—Dexamethasone—atopic dermatitis	0.0026	0.00942	CbGbCtD
Imipramine—CYP3A4—Loratadine—atopic dermatitis	0.00231	0.00837	CbGbCtD
Imipramine—ABCB1—Betamethasone—atopic dermatitis	0.00229	0.0083	CbGbCtD
Imipramine—ABCB1—Prednisolone—atopic dermatitis	0.00226	0.00819	CbGbCtD
Imipramine—ABCB1—Hydrocortisone—atopic dermatitis	0.00214	0.00777	CbGbCtD
Imipramine—ABCB1—Prednisone—atopic dermatitis	0.00213	0.00774	CbGbCtD
Imipramine—CYP3A4—Methylprednisolone—atopic dermatitis	0.00211	0.00765	CbGbCtD
Imipramine—CYP2C19—Dexamethasone—atopic dermatitis	0.00165	0.00599	CbGbCtD
Imipramine—CYP3A4—Triamcinolone—atopic dermatitis	0.0016	0.0058	CbGbCtD
Imipramine—CYP3A4—Betamethasone—atopic dermatitis	0.00137	0.00497	CbGbCtD
Imipramine—CYP3A4—Prednisolone—atopic dermatitis	0.00135	0.00491	CbGbCtD
Imipramine—ABCB1—Dexamethasone—atopic dermatitis	0.00133	0.00483	CbGbCtD
Imipramine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00128	0.00465	CbGbCtD
Imipramine—CYP3A4—Prednisone—atopic dermatitis	0.00128	0.00464	CbGbCtD
Imipramine—CYP2D6—Dexamethasone—atopic dermatitis	0.00126	0.00455	CbGbCtD
Imipramine—CYP3A4—Dexamethasone—atopic dermatitis	0.000798	0.00289	CbGbCtD
Imipramine—CHRM5—skin epidermis—atopic dermatitis	0.000396	0.169	CbGeAlD
Imipramine—SLC22A4—neck—atopic dermatitis	0.000134	0.0572	CbGeAlD
Imipramine—KCND2—head—atopic dermatitis	0.000123	0.0526	CbGeAlD
Imipramine—CHRM5—skin of body—atopic dermatitis	0.000123	0.0523	CbGeAlD
Imipramine—KCND3—head—atopic dermatitis	0.000107	0.0458	CbGeAlD
Imipramine—CHRM4—head—atopic dermatitis	0.000102	0.0437	CbGeAlD
Imipramine—HTR7—neck—atopic dermatitis	0.000101	0.043	CbGeAlD
Imipramine—HTR6—head—atopic dermatitis	9.16e-05	0.0391	CbGeAlD
Imipramine—CHRM5—head—atopic dermatitis	8e-05	0.0341	CbGeAlD
Imipramine—ADRA1B—head—atopic dermatitis	7.31e-05	0.0312	CbGeAlD
Imipramine—ADRA1D—head—atopic dermatitis	7.15e-05	0.0305	CbGeAlD
Imipramine—HTR2A—neck—atopic dermatitis	6.29e-05	0.0268	CbGeAlD
Imipramine—CHRM2—head—atopic dermatitis	5.49e-05	0.0234	CbGeAlD
Imipramine—SLC6A3—head—atopic dermatitis	5.48e-05	0.0234	CbGeAlD
Imipramine—SLC22A1—head—atopic dermatitis	5.4e-05	0.023	CbGeAlD
Imipramine—HTR2C—head—atopic dermatitis	5.3e-05	0.0226	CbGeAlD
Imipramine—SLC22A3—head—atopic dermatitis	5.16e-05	0.022	CbGeAlD
Imipramine—SLC6A4—head—atopic dermatitis	5.02e-05	0.0214	CbGeAlD
Imipramine—CHRM1—head—atopic dermatitis	5e-05	0.0213	CbGeAlD
Imipramine—CYP2B6—skin of body—atopic dermatitis	4.99e-05	0.0213	CbGeAlD
Imipramine—Angiopathy—Betamethasone—atopic dermatitis	4.83e-05	0.00071	CcSEcCtD
Imipramine—Angiopathy—Dexamethasone—atopic dermatitis	4.83e-05	0.00071	CcSEcCtD
Imipramine—Convulsion—Prednisolone—atopic dermatitis	4.81e-05	0.000707	CcSEcCtD
Imipramine—Hypertension—Prednisolone—atopic dermatitis	4.8e-05	0.000705	CcSEcCtD
Imipramine—Loss of consciousness—Hydrocortisone—atopic dermatitis	4.77e-05	0.000701	CcSEcCtD
Imipramine—Arrhythmia—Dexamethasone—atopic dermatitis	4.76e-05	0.000699	CcSEcCtD
Imipramine—Arrhythmia—Betamethasone—atopic dermatitis	4.76e-05	0.000699	CcSEcCtD
Imipramine—Ill-defined disorder—Triamcinolone—atopic dermatitis	4.74e-05	0.000697	CcSEcCtD
Imipramine—Ill-defined disorder—Methylprednisolone—atopic dermatitis	4.73e-05	0.000695	CcSEcCtD
Imipramine—Alopecia—Betamethasone—atopic dermatitis	4.71e-05	0.000691	CcSEcCtD
Imipramine—Alopecia—Dexamethasone—atopic dermatitis	4.71e-05	0.000691	CcSEcCtD
Imipramine—Convulsion—Hydrocortisone—atopic dermatitis	4.7e-05	0.000691	CcSEcCtD
Imipramine—Dizziness—Tacrolimus—atopic dermatitis	4.7e-05	0.00069	CcSEcCtD
Imipramine—Hypertension—Hydrocortisone—atopic dermatitis	4.69e-05	0.000688	CcSEcCtD
Imipramine—Discomfort—Prednisolone—atopic dermatitis	4.67e-05	0.000687	CcSEcCtD
Imipramine—Hallucination—Prednisone—atopic dermatitis	4.62e-05	0.000678	CcSEcCtD
Imipramine—Malaise—Triamcinolone—atopic dermatitis	4.61e-05	0.000677	CcSEcCtD
Imipramine—Anxiety—Hydrocortisone—atopic dermatitis	4.6e-05	0.000676	CcSEcCtD
Imipramine—Malaise—Methylprednisolone—atopic dermatitis	4.6e-05	0.000676	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	4.59e-05	0.000674	CcSEcCtD
Imipramine—Syncope—Triamcinolone—atopic dermatitis	4.58e-05	0.000673	CcSEcCtD
Imipramine—Syncope—Methylprednisolone—atopic dermatitis	4.57e-05	0.000672	CcSEcCtD
Imipramine—Discomfort—Hydrocortisone—atopic dermatitis	4.57e-05	0.000671	CcSEcCtD
Imipramine—Oedema—Prednisolone—atopic dermatitis	4.54e-05	0.000666	CcSEcCtD
Imipramine—Anaphylactic shock—Prednisolone—atopic dermatitis	4.54e-05	0.000666	CcSEcCtD
Imipramine—Vomiting—Tacrolimus—atopic dermatitis	4.51e-05	0.000663	CcSEcCtD
Imipramine—Loss of consciousness—Triamcinolone—atopic dermatitis	4.49e-05	0.00066	CcSEcCtD
Imipramine—Loss of consciousness—Methylprednisolone—atopic dermatitis	4.48e-05	0.000658	CcSEcCtD
Imipramine—Rash—Tacrolimus—atopic dermatitis	4.48e-05	0.000658	CcSEcCtD
Imipramine—CHRM3—head—atopic dermatitis	4.47e-05	0.0191	CbGeAlD
Imipramine—Dermatitis—Tacrolimus—atopic dermatitis	4.47e-05	0.000657	CcSEcCtD
Imipramine—Shock—Prednisolone—atopic dermatitis	4.46e-05	0.000656	CcSEcCtD
Imipramine—HTR1A—head—atopic dermatitis	4.46e-05	0.019	CbGeAlD
Imipramine—Headache—Tacrolimus—atopic dermatitis	4.45e-05	0.000653	CcSEcCtD
Imipramine—Oedema—Hydrocortisone—atopic dermatitis	4.43e-05	0.000651	CcSEcCtD
Imipramine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	4.43e-05	0.000651	CcSEcCtD
Imipramine—Convulsion—Triamcinolone—atopic dermatitis	4.43e-05	0.00065	CcSEcCtD
Imipramine—Tachycardia—Prednisolone—atopic dermatitis	4.43e-05	0.00065	CcSEcCtD
Imipramine—SLC6A2—head—atopic dermatitis	4.42e-05	0.0188	CbGeAlD
Imipramine—Convulsion—Methylprednisolone—atopic dermatitis	4.42e-05	0.000649	CcSEcCtD
Imipramine—Hypertension—Triamcinolone—atopic dermatitis	4.41e-05	0.000648	CcSEcCtD
Imipramine—Hypertension—Methylprednisolone—atopic dermatitis	4.4e-05	0.000647	CcSEcCtD
Imipramine—Infection—Hydrocortisone—atopic dermatitis	4.4e-05	0.000646	CcSEcCtD
Imipramine—Hyperhidrosis—Prednisolone—atopic dermatitis	4.38e-05	0.000644	CcSEcCtD
Imipramine—Shock—Hydrocortisone—atopic dermatitis	4.36e-05	0.00064	CcSEcCtD
Imipramine—Nervous system disorder—Hydrocortisone—atopic dermatitis	4.34e-05	0.000638	CcSEcCtD
Imipramine—Eye disorder—Prednisone—atopic dermatitis	4.33e-05	0.000637	CcSEcCtD
Imipramine—Anxiety—Methylprednisolone—atopic dermatitis	4.33e-05	0.000636	CcSEcCtD
Imipramine—Tachycardia—Hydrocortisone—atopic dermatitis	4.32e-05	0.000635	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	4.31e-05	0.000633	CcSEcCtD
Imipramine—Flushing—Prednisone—atopic dermatitis	4.31e-05	0.000632	CcSEcCtD
Imipramine—Skin disorder—Hydrocortisone—atopic dermatitis	4.3e-05	0.000632	CcSEcCtD
Imipramine—Ill-defined disorder—Dexamethasone—atopic dermatitis	4.3e-05	0.000632	CcSEcCtD
Imipramine—Ill-defined disorder—Betamethasone—atopic dermatitis	4.3e-05	0.000632	CcSEcCtD
Imipramine—Discomfort—Triamcinolone—atopic dermatitis	4.3e-05	0.000631	CcSEcCtD
Imipramine—Discomfort—Methylprednisolone—atopic dermatitis	4.29e-05	0.00063	CcSEcCtD
Imipramine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	4.28e-05	0.000629	CcSEcCtD
Imipramine—HTR7—head—atopic dermatitis	4.26e-05	0.0182	CbGeAlD
Imipramine—Dry mouth—Triamcinolone—atopic dermatitis	4.25e-05	0.000625	CcSEcCtD
Imipramine—Anorexia—Hydrocortisone—atopic dermatitis	4.22e-05	0.00062	CcSEcCtD
Imipramine—Nausea—Tacrolimus—atopic dermatitis	4.22e-05	0.00062	CcSEcCtD
Imipramine—Angiopathy—Prednisone—atopic dermatitis	4.21e-05	0.000618	CcSEcCtD
Imipramine—Confusional state—Methylprednisolone—atopic dermatitis	4.2e-05	0.000616	CcSEcCtD
Imipramine—Immune system disorder—Prednisone—atopic dermatitis	4.19e-05	0.000616	CcSEcCtD
Imipramine—Malaise—Dexamethasone—atopic dermatitis	4.18e-05	0.000614	CcSEcCtD
Imipramine—Malaise—Betamethasone—atopic dermatitis	4.18e-05	0.000614	CcSEcCtD
Imipramine—Anaphylactic shock—Triamcinolone—atopic dermatitis	4.17e-05	0.000613	CcSEcCtD
Imipramine—Oedema—Triamcinolone—atopic dermatitis	4.17e-05	0.000613	CcSEcCtD
Imipramine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	4.16e-05	0.000611	CcSEcCtD
Imipramine—Syncope—Dexamethasone—atopic dermatitis	4.16e-05	0.000611	CcSEcCtD
Imipramine—Syncope—Betamethasone—atopic dermatitis	4.16e-05	0.000611	CcSEcCtD
Imipramine—Arrhythmia—Prednisone—atopic dermatitis	4.14e-05	0.000609	CcSEcCtD
Imipramine—Infection—Triamcinolone—atopic dermatitis	4.14e-05	0.000609	CcSEcCtD
Imipramine—Infection—Methylprednisolone—atopic dermatitis	4.13e-05	0.000607	CcSEcCtD
Imipramine—ADRA1A—head—atopic dermatitis	4.11e-05	0.0175	CbGeAlD
Imipramine—Shock—Triamcinolone—atopic dermatitis	4.1e-05	0.000603	CcSEcCtD
Imipramine—Insomnia—Prednisolone—atopic dermatitis	4.1e-05	0.000603	CcSEcCtD
Imipramine—Alopecia—Prednisone—atopic dermatitis	4.1e-05	0.000602	CcSEcCtD
Imipramine—Shock—Methylprednisolone—atopic dermatitis	4.09e-05	0.000601	CcSEcCtD
Imipramine—Nervous system disorder—Methylprednisolone—atopic dermatitis	4.08e-05	0.0006	CcSEcCtD
Imipramine—Loss of consciousness—Dexamethasone—atopic dermatitis	4.08e-05	0.000599	CcSEcCtD
Imipramine—Loss of consciousness—Betamethasone—atopic dermatitis	4.08e-05	0.000599	CcSEcCtD
Imipramine—Paraesthesia—Prednisolone—atopic dermatitis	4.07e-05	0.000598	CcSEcCtD
Imipramine—Tachycardia—Triamcinolone—atopic dermatitis	4.07e-05	0.000598	CcSEcCtD
Imipramine—Mental disorder—Prednisone—atopic dermatitis	4.06e-05	0.000597	CcSEcCtD
Imipramine—Tachycardia—Methylprednisolone—atopic dermatitis	4.06e-05	0.000597	CcSEcCtD
Imipramine—Skin disorder—Methylprednisolone—atopic dermatitis	4.04e-05	0.000594	CcSEcCtD
Imipramine—Malnutrition—Prednisone—atopic dermatitis	4.04e-05	0.000593	CcSEcCtD
Imipramine—Hyperhidrosis—Triamcinolone—atopic dermatitis	4.03e-05	0.000592	CcSEcCtD
Imipramine—DRD2—head—atopic dermatitis	4.03e-05	0.0172	CbGeAlD
Imipramine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	4.02e-05	0.000591	CcSEcCtD
Imipramine—Convulsion—Dexamethasone—atopic dermatitis	4.02e-05	0.00059	CcSEcCtD
Imipramine—Convulsion—Betamethasone—atopic dermatitis	4.02e-05	0.00059	CcSEcCtD
Imipramine—Insomnia—Hydrocortisone—atopic dermatitis	4.01e-05	0.000589	CcSEcCtD
Imipramine—Hypertension—Betamethasone—atopic dermatitis	4e-05	0.000588	CcSEcCtD
Imipramine—Hypertension—Dexamethasone—atopic dermatitis	4e-05	0.000588	CcSEcCtD
Imipramine—Paraesthesia—Hydrocortisone—atopic dermatitis	3.98e-05	0.000584	CcSEcCtD
Imipramine—KCNH2—head—atopic dermatitis	3.97e-05	0.0169	CbGeAlD
Imipramine—Anxiety—Dexamethasone—atopic dermatitis	3.93e-05	0.000578	CcSEcCtD
Imipramine—Anxiety—Betamethasone—atopic dermatitis	3.93e-05	0.000578	CcSEcCtD
Imipramine—Discomfort—Dexamethasone—atopic dermatitis	3.9e-05	0.000573	CcSEcCtD
Imipramine—Discomfort—Betamethasone—atopic dermatitis	3.9e-05	0.000573	CcSEcCtD
Imipramine—Dyspepsia—Hydrocortisone—atopic dermatitis	3.9e-05	0.000573	CcSEcCtD
Imipramine—Decreased appetite—Hydrocortisone—atopic dermatitis	3.85e-05	0.000566	CcSEcCtD
Imipramine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	3.82e-05	0.000562	CcSEcCtD
Imipramine—Fatigue—Hydrocortisone—atopic dermatitis	3.82e-05	0.000561	CcSEcCtD
Imipramine—Vision blurred—Prednisone—atopic dermatitis	3.81e-05	0.000559	CcSEcCtD
Imipramine—Anaphylactic shock—Betamethasone—atopic dermatitis	3.78e-05	0.000556	CcSEcCtD
Imipramine—Oedema—Betamethasone—atopic dermatitis	3.78e-05	0.000556	CcSEcCtD
Imipramine—Anaphylactic shock—Dexamethasone—atopic dermatitis	3.78e-05	0.000556	CcSEcCtD
Imipramine—Oedema—Dexamethasone—atopic dermatitis	3.78e-05	0.000556	CcSEcCtD
Imipramine—Insomnia—Triamcinolone—atopic dermatitis	3.77e-05	0.000554	CcSEcCtD
Imipramine—Insomnia—Methylprednisolone—atopic dermatitis	3.76e-05	0.000553	CcSEcCtD
Imipramine—Infection—Betamethasone—atopic dermatitis	3.76e-05	0.000552	CcSEcCtD
Imipramine—Infection—Dexamethasone—atopic dermatitis	3.76e-05	0.000552	CcSEcCtD
Imipramine—Ill-defined disorder—Prednisone—atopic dermatitis	3.75e-05	0.00055	CcSEcCtD
Imipramine—Paraesthesia—Triamcinolone—atopic dermatitis	3.74e-05	0.00055	CcSEcCtD
Imipramine—Feeling abnormal—Prednisolone—atopic dermatitis	3.74e-05	0.000549	CcSEcCtD
Imipramine—Paraesthesia—Methylprednisolone—atopic dermatitis	3.74e-05	0.000549	CcSEcCtD
Imipramine—Shock—Dexamethasone—atopic dermatitis	3.72e-05	0.000547	CcSEcCtD
Imipramine—Shock—Betamethasone—atopic dermatitis	3.72e-05	0.000547	CcSEcCtD
Imipramine—Nervous system disorder—Betamethasone—atopic dermatitis	3.71e-05	0.000545	CcSEcCtD
Imipramine—Nervous system disorder—Dexamethasone—atopic dermatitis	3.71e-05	0.000545	CcSEcCtD
Imipramine—Agitation—Prednisone—atopic dermatitis	3.71e-05	0.000545	CcSEcCtD
Imipramine—Thrombocytopenia—Dexamethasone—atopic dermatitis	3.71e-05	0.000544	CcSEcCtD
Imipramine—Thrombocytopenia—Betamethasone—atopic dermatitis	3.71e-05	0.000544	CcSEcCtD
Imipramine—Tachycardia—Dexamethasone—atopic dermatitis	3.69e-05	0.000543	CcSEcCtD
Imipramine—Tachycardia—Betamethasone—atopic dermatitis	3.69e-05	0.000543	CcSEcCtD
Imipramine—Dyspepsia—Triamcinolone—atopic dermatitis	3.67e-05	0.000539	CcSEcCtD
Imipramine—Dyspepsia—Methylprednisolone—atopic dermatitis	3.66e-05	0.000538	CcSEcCtD
Imipramine—Hyperhidrosis—Dexamethasone—atopic dermatitis	3.66e-05	0.000537	CcSEcCtD
Imipramine—Hyperhidrosis—Betamethasone—atopic dermatitis	3.66e-05	0.000537	CcSEcCtD
Imipramine—Feeling abnormal—Hydrocortisone—atopic dermatitis	3.65e-05	0.000536	CcSEcCtD
Imipramine—Malaise—Prednisone—atopic dermatitis	3.64e-05	0.000535	CcSEcCtD
Imipramine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	3.62e-05	0.000532	CcSEcCtD
Imipramine—Syncope—Prednisone—atopic dermatitis	3.62e-05	0.000532	CcSEcCtD
Imipramine—Anorexia—Dexamethasone—atopic dermatitis	3.61e-05	0.00053	CcSEcCtD
Imipramine—Anorexia—Betamethasone—atopic dermatitis	3.61e-05	0.00053	CcSEcCtD
Imipramine—Urticaria—Prednisolone—atopic dermatitis	3.6e-05	0.000529	CcSEcCtD
Imipramine—Fatigue—Triamcinolone—atopic dermatitis	3.6e-05	0.000528	CcSEcCtD
Imipramine—Fatigue—Methylprednisolone—atopic dermatitis	3.59e-05	0.000527	CcSEcCtD
Imipramine—Loss of consciousness—Prednisone—atopic dermatitis	3.55e-05	0.000521	CcSEcCtD
Imipramine—Urticaria—Hydrocortisone—atopic dermatitis	3.52e-05	0.000517	CcSEcCtD
Imipramine—Abdominal pain—Hydrocortisone—atopic dermatitis	3.5e-05	0.000514	CcSEcCtD
Imipramine—Body temperature increased—Hydrocortisone—atopic dermatitis	3.5e-05	0.000514	CcSEcCtD
Imipramine—Convulsion—Prednisone—atopic dermatitis	3.5e-05	0.000514	CcSEcCtD
Imipramine—Hypertension—Prednisone—atopic dermatitis	3.49e-05	0.000512	CcSEcCtD
Imipramine—Feeling abnormal—Triamcinolone—atopic dermatitis	3.44e-05	0.000505	CcSEcCtD
Imipramine—Feeling abnormal—Methylprednisolone—atopic dermatitis	3.43e-05	0.000504	CcSEcCtD
Imipramine—Anxiety—Prednisone—atopic dermatitis	3.43e-05	0.000503	CcSEcCtD
Imipramine—Insomnia—Betamethasone—atopic dermatitis	3.42e-05	0.000503	CcSEcCtD
Imipramine—Insomnia—Dexamethasone—atopic dermatitis	3.42e-05	0.000503	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	3.41e-05	0.000502	CcSEcCtD
Imipramine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	3.4e-05	0.0005	CcSEcCtD
Imipramine—Paraesthesia—Betamethasone—atopic dermatitis	3.4e-05	0.000499	CcSEcCtD
Imipramine—Paraesthesia—Dexamethasone—atopic dermatitis	3.4e-05	0.000499	CcSEcCtD
Imipramine—Discomfort—Prednisone—atopic dermatitis	3.4e-05	0.000499	CcSEcCtD
Imipramine—Dyspepsia—Betamethasone—atopic dermatitis	3.33e-05	0.000489	CcSEcCtD
Imipramine—Dyspepsia—Dexamethasone—atopic dermatitis	3.33e-05	0.000489	CcSEcCtD
Imipramine—Urticaria—Triamcinolone—atopic dermatitis	3.31e-05	0.000487	CcSEcCtD
Imipramine—Urticaria—Methylprednisolone—atopic dermatitis	3.31e-05	0.000486	CcSEcCtD
Imipramine—Body temperature increased—Triamcinolone—atopic dermatitis	3.3e-05	0.000484	CcSEcCtD
Imipramine—Anaphylactic shock—Prednisone—atopic dermatitis	3.3e-05	0.000484	CcSEcCtD
Imipramine—Oedema—Prednisone—atopic dermatitis	3.3e-05	0.000484	CcSEcCtD
Imipramine—Abdominal pain—Methylprednisolone—atopic dermatitis	3.29e-05	0.000483	CcSEcCtD
Imipramine—Decreased appetite—Dexamethasone—atopic dermatitis	3.29e-05	0.000483	CcSEcCtD
Imipramine—Decreased appetite—Betamethasone—atopic dermatitis	3.29e-05	0.000483	CcSEcCtD
Imipramine—Infection—Prednisone—atopic dermatitis	3.27e-05	0.000481	CcSEcCtD
Imipramine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	3.27e-05	0.00048	CcSEcCtD
Imipramine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	3.27e-05	0.00048	CcSEcCtD
Imipramine—Fatigue—Betamethasone—atopic dermatitis	3.26e-05	0.000479	CcSEcCtD
Imipramine—Fatigue—Dexamethasone—atopic dermatitis	3.26e-05	0.000479	CcSEcCtD
Imipramine—CYP2B6—head—atopic dermatitis	3.26e-05	0.0139	CbGeAlD
Imipramine—Shock—Prednisone—atopic dermatitis	3.24e-05	0.000476	CcSEcCtD
Imipramine—Nervous system disorder—Prednisone—atopic dermatitis	3.23e-05	0.000475	CcSEcCtD
Imipramine—Tachycardia—Prednisone—atopic dermatitis	3.22e-05	0.000473	CcSEcCtD
Imipramine—Skin disorder—Prednisone—atopic dermatitis	3.2e-05	0.00047	CcSEcCtD
Imipramine—Hyperhidrosis—Prednisone—atopic dermatitis	3.19e-05	0.000468	CcSEcCtD
Imipramine—HRH1—head—atopic dermatitis	3.18e-05	0.0136	CbGeAlD
Imipramine—Asthenia—Hydrocortisone—atopic dermatitis	3.18e-05	0.000467	CcSEcCtD
Imipramine—Anorexia—Prednisone—atopic dermatitis	3.14e-05	0.000462	CcSEcCtD
Imipramine—Pruritus—Hydrocortisone—atopic dermatitis	3.13e-05	0.00046	CcSEcCtD
Imipramine—Feeling abnormal—Betamethasone—atopic dermatitis	3.12e-05	0.000458	CcSEcCtD
Imipramine—Feeling abnormal—Dexamethasone—atopic dermatitis	3.12e-05	0.000458	CcSEcCtD
Imipramine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	3.09e-05	0.000455	CcSEcCtD
Imipramine—Gastrointestinal pain—Betamethasone—atopic dermatitis	3.09e-05	0.000455	CcSEcCtD
Imipramine—CYP2E1—head—atopic dermatitis	3.06e-05	0.013	CbGeAlD
Imipramine—Diarrhoea—Hydrocortisone—atopic dermatitis	3.03e-05	0.000445	CcSEcCtD
Imipramine—Urticaria—Dexamethasone—atopic dermatitis	3.01e-05	0.000442	CcSEcCtD
Imipramine—Urticaria—Betamethasone—atopic dermatitis	3.01e-05	0.000442	CcSEcCtD
Imipramine—Dizziness—Prednisolone—atopic dermatitis	3e-05	0.000441	CcSEcCtD
Imipramine—Asthenia—Triamcinolone—atopic dermatitis	2.99e-05	0.00044	CcSEcCtD
Imipramine—Body temperature increased—Betamethasone—atopic dermatitis	2.99e-05	0.000439	CcSEcCtD
Imipramine—Abdominal pain—Dexamethasone—atopic dermatitis	2.99e-05	0.000439	CcSEcCtD
Imipramine—Abdominal pain—Betamethasone—atopic dermatitis	2.99e-05	0.000439	CcSEcCtD
Imipramine—Body temperature increased—Dexamethasone—atopic dermatitis	2.99e-05	0.000439	CcSEcCtD
Imipramine—Asthenia—Methylprednisolone—atopic dermatitis	2.99e-05	0.000439	CcSEcCtD
Imipramine—Insomnia—Prednisone—atopic dermatitis	2.98e-05	0.000438	CcSEcCtD
Imipramine—Paraesthesia—Prednisone—atopic dermatitis	2.96e-05	0.000435	CcSEcCtD
Imipramine—Pruritus—Triamcinolone—atopic dermatitis	2.95e-05	0.000433	CcSEcCtD
Imipramine—Pruritus—Methylprednisolone—atopic dermatitis	2.94e-05	0.000433	CcSEcCtD
Imipramine—Dizziness—Hydrocortisone—atopic dermatitis	2.93e-05	0.00043	CcSEcCtD
Imipramine—Dyspepsia—Prednisone—atopic dermatitis	2.9e-05	0.000426	CcSEcCtD
Imipramine—Decreased appetite—Prednisone—atopic dermatitis	2.86e-05	0.000421	CcSEcCtD
Imipramine—Rash—Prednisolone—atopic dermatitis	2.86e-05	0.00042	CcSEcCtD
Imipramine—Dermatitis—Prednisolone—atopic dermatitis	2.86e-05	0.00042	CcSEcCtD
Imipramine—Diarrhoea—Methylprednisolone—atopic dermatitis	2.85e-05	0.000418	CcSEcCtD
Imipramine—Fatigue—Prednisone—atopic dermatitis	2.84e-05	0.000417	CcSEcCtD
Imipramine—Headache—Prednisolone—atopic dermatitis	2.84e-05	0.000417	CcSEcCtD
Imipramine—Constipation—Prednisone—atopic dermatitis	2.82e-05	0.000414	CcSEcCtD
Imipramine—Vomiting—Hydrocortisone—atopic dermatitis	2.82e-05	0.000414	CcSEcCtD
Imipramine—Rash—Hydrocortisone—atopic dermatitis	2.79e-05	0.00041	CcSEcCtD
Imipramine—Dermatitis—Hydrocortisone—atopic dermatitis	2.79e-05	0.00041	CcSEcCtD
Imipramine—Headache—Hydrocortisone—atopic dermatitis	2.77e-05	0.000408	CcSEcCtD
Imipramine—Dizziness—Triamcinolone—atopic dermatitis	2.76e-05	0.000405	CcSEcCtD
Imipramine—Dizziness—Methylprednisolone—atopic dermatitis	2.75e-05	0.000404	CcSEcCtD
Imipramine—Feeling abnormal—Prednisone—atopic dermatitis	2.72e-05	0.000399	CcSEcCtD
Imipramine—Asthenia—Betamethasone—atopic dermatitis	2.72e-05	0.000399	CcSEcCtD
Imipramine—Asthenia—Dexamethasone—atopic dermatitis	2.72e-05	0.000399	CcSEcCtD
Imipramine—Gastrointestinal pain—Prednisone—atopic dermatitis	2.69e-05	0.000396	CcSEcCtD
Imipramine—Nausea—Prednisolone—atopic dermatitis	2.69e-05	0.000396	CcSEcCtD
Imipramine—Pruritus—Betamethasone—atopic dermatitis	2.68e-05	0.000393	CcSEcCtD
Imipramine—Pruritus—Dexamethasone—atopic dermatitis	2.68e-05	0.000393	CcSEcCtD
Imipramine—HTR2A—head—atopic dermatitis	2.66e-05	0.0113	CbGeAlD
Imipramine—Vomiting—Triamcinolone—atopic dermatitis	2.65e-05	0.00039	CcSEcCtD
Imipramine—Vomiting—Methylprednisolone—atopic dermatitis	2.65e-05	0.000389	CcSEcCtD
Imipramine—Nausea—Hydrocortisone—atopic dermatitis	2.63e-05	0.000387	CcSEcCtD
Imipramine—Rash—Triamcinolone—atopic dermatitis	2.63e-05	0.000386	CcSEcCtD
Imipramine—Dermatitis—Triamcinolone—atopic dermatitis	2.63e-05	0.000386	CcSEcCtD
Imipramine—Rash—Methylprednisolone—atopic dermatitis	2.62e-05	0.000385	CcSEcCtD
Imipramine—Dermatitis—Methylprednisolone—atopic dermatitis	2.62e-05	0.000385	CcSEcCtD
Imipramine—Urticaria—Prednisone—atopic dermatitis	2.62e-05	0.000385	CcSEcCtD
Imipramine—Headache—Triamcinolone—atopic dermatitis	2.61e-05	0.000384	CcSEcCtD
Imipramine—Headache—Methylprednisolone—atopic dermatitis	2.61e-05	0.000383	CcSEcCtD
Imipramine—Body temperature increased—Prednisone—atopic dermatitis	2.61e-05	0.000383	CcSEcCtD
Imipramine—Abdominal pain—Prednisone—atopic dermatitis	2.61e-05	0.000383	CcSEcCtD
Imipramine—Diarrhoea—Betamethasone—atopic dermatitis	2.59e-05	0.00038	CcSEcCtD
Imipramine—Diarrhoea—Dexamethasone—atopic dermatitis	2.59e-05	0.00038	CcSEcCtD
Imipramine—Dizziness—Dexamethasone—atopic dermatitis	2.5e-05	0.000368	CcSEcCtD
Imipramine—Dizziness—Betamethasone—atopic dermatitis	2.5e-05	0.000368	CcSEcCtD
Imipramine—Nausea—Triamcinolone—atopic dermatitis	2.48e-05	0.000364	CcSEcCtD
Imipramine—Nausea—Methylprednisolone—atopic dermatitis	2.47e-05	0.000363	CcSEcCtD
Imipramine—CYP2D6—head—atopic dermatitis	2.42e-05	0.0103	CbGeAlD
Imipramine—Vomiting—Betamethasone—atopic dermatitis	2.41e-05	0.000353	CcSEcCtD
Imipramine—Vomiting—Dexamethasone—atopic dermatitis	2.41e-05	0.000353	CcSEcCtD
Imipramine—Rash—Betamethasone—atopic dermatitis	2.39e-05	0.000351	CcSEcCtD
Imipramine—Rash—Dexamethasone—atopic dermatitis	2.39e-05	0.000351	CcSEcCtD
Imipramine—Dermatitis—Dexamethasone—atopic dermatitis	2.38e-05	0.00035	CcSEcCtD
Imipramine—Dermatitis—Betamethasone—atopic dermatitis	2.38e-05	0.00035	CcSEcCtD
Imipramine—Headache—Betamethasone—atopic dermatitis	2.37e-05	0.000348	CcSEcCtD
Imipramine—Headache—Dexamethasone—atopic dermatitis	2.37e-05	0.000348	CcSEcCtD
Imipramine—Asthenia—Prednisone—atopic dermatitis	2.36e-05	0.000347	CcSEcCtD
Imipramine—Pruritus—Prednisone—atopic dermatitis	2.33e-05	0.000343	CcSEcCtD
Imipramine—Diarrhoea—Prednisone—atopic dermatitis	2.25e-05	0.000331	CcSEcCtD
Imipramine—Nausea—Dexamethasone—atopic dermatitis	2.25e-05	0.00033	CcSEcCtD
Imipramine—Nausea—Betamethasone—atopic dermatitis	2.25e-05	0.00033	CcSEcCtD
Imipramine—Dizziness—Prednisone—atopic dermatitis	2.18e-05	0.00032	CcSEcCtD
Imipramine—Vomiting—Prednisone—atopic dermatitis	2.1e-05	0.000308	CcSEcCtD
Imipramine—Rash—Prednisone—atopic dermatitis	2.08e-05	0.000305	CcSEcCtD
Imipramine—Dermatitis—Prednisone—atopic dermatitis	2.08e-05	0.000305	CcSEcCtD
Imipramine—Headache—Prednisone—atopic dermatitis	2.06e-05	0.000303	CcSEcCtD
Imipramine—Nausea—Prednisone—atopic dermatitis	1.96e-05	0.000288	CcSEcCtD
Imipramine—ABCB1—head—atopic dermatitis	1.74e-05	0.00742	CbGeAlD
Imipramine—HTR6—GPCR downstream signaling—IL2—atopic dermatitis	4.16e-06	0.0002	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	4.16e-06	0.0002	CbGpPWpGaD
Imipramine—HTR7—GPCR downstream signaling—IL2—atopic dermatitis	4.15e-06	0.0002	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—CCR5—atopic dermatitis	4.14e-06	0.000199	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL5—atopic dermatitis	4.11e-06	0.000198	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—CXCL8—atopic dermatitis	4.1e-06	0.000197	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—CCR5—atopic dermatitis	4.1e-06	0.000197	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.1e-06	0.000197	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—CCR5—atopic dermatitis	4.09e-06	0.000197	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TAC1—atopic dermatitis	4.08e-06	0.000196	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NPS—atopic dermatitis	4.08e-06	0.000196	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CCL5—atopic dermatitis	4.04e-06	0.000194	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	4.01e-06	0.000193	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NPS—atopic dermatitis	4.01e-06	0.000193	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NPS—atopic dermatitis	4.01e-06	0.000193	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TAC1—atopic dermatitis	4.01e-06	0.000193	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	4e-06	0.000192	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NPS—atopic dermatitis	3.99e-06	0.000192	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	3.99e-06	0.000192	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NPS—atopic dermatitis	3.98e-06	0.000191	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TAC1—atopic dermatitis	3.98e-06	0.000191	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—NGF—atopic dermatitis	3.97e-06	0.000191	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—NGF—atopic dermatitis	3.96e-06	0.000191	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—CXCL8—atopic dermatitis	3.95e-06	0.00019	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—CXCL8—atopic dermatitis	3.95e-06	0.00019	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TAC1—atopic dermatitis	3.94e-06	0.00019	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NPS—atopic dermatitis	3.94e-06	0.00019	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	3.94e-06	0.000189	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TAC1—atopic dermatitis	3.93e-06	0.000189	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NPS—atopic dermatitis	3.93e-06	0.000189	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—CXCL8—atopic dermatitis	3.93e-06	0.000189	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CXCR3—atopic dermatitis	3.93e-06	0.000189	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—IL2—atopic dermatitis	3.92e-06	0.000189	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	3.92e-06	0.000188	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CXCR3—atopic dermatitis	3.9e-06	0.000188	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CCL5—atopic dermatitis	3.87e-06	0.000186	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CXCR3—atopic dermatitis	3.87e-06	0.000186	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CCR5—atopic dermatitis	3.86e-06	0.000186	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CXCR3—atopic dermatitis	3.85e-06	0.000185	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CCR5—atopic dermatitis	3.85e-06	0.000185	CbGpPWpGaD
Imipramine—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.8e-06	0.000183	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL5—atopic dermatitis	3.79e-06	0.000182	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—IL2—atopic dermatitis	3.77e-06	0.000182	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—IL2—atopic dermatitis	3.77e-06	0.000181	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—IL2—atopic dermatitis	3.75e-06	0.000181	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—NGF—atopic dermatitis	3.74e-06	0.00018	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL5—atopic dermatitis	3.73e-06	0.000179	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—CXCL8—atopic dermatitis	3.73e-06	0.000179	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL5—atopic dermatitis	3.72e-06	0.000179	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL5—atopic dermatitis	3.71e-06	0.000179	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL5—atopic dermatitis	3.7e-06	0.000178	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—CXCL8—atopic dermatitis	3.69e-06	0.000178	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	3.68e-06	0.000177	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	3.66e-06	0.000176	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL5—atopic dermatitis	3.66e-06	0.000176	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	3.65e-06	0.000176	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CCR5—atopic dermatitis	3.64e-06	0.000175	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CCL5—atopic dermatitis	3.64e-06	0.000175	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—NGF—atopic dermatitis	3.58e-06	0.000172	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—CXCL8—atopic dermatitis	3.57e-06	0.000172	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—IL2—atopic dermatitis	3.56e-06	0.000171	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—IL2—atopic dermatitis	3.53e-06	0.00017	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CXCL10—atopic dermatitis	3.51e-06	0.000169	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CCR5—atopic dermatitis	3.49e-06	0.000168	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—IL2—atopic dermatitis	3.41e-06	0.000164	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.38e-06	0.000163	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—NGF—atopic dermatitis	3.37e-06	0.000162	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—CXCL8—atopic dermatitis	3.35e-06	0.000161	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CCR5—atopic dermatitis	3.28e-06	0.000158	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—NFKBIA—atopic dermatitis	3.27e-06	0.000157	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—NFKBIA—atopic dermatitis	3.27e-06	0.000157	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—PPARA—atopic dermatitis	3.26e-06	0.000157	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—PPARA—atopic dermatitis	3.26e-06	0.000157	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.24e-06	0.000156	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	3.23e-06	0.000156	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	3.22e-06	0.000155	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—IL2—atopic dermatitis	3.21e-06	0.000154	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	3.2e-06	0.000154	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.19e-06	0.000153	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	3.18e-06	0.000153	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	3.18e-06	0.000153	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	3.17e-06	0.000152	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	3.17e-06	0.000152	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	3.16e-06	0.000152	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	3.15e-06	0.000152	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	3.12e-06	0.00015	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	3.12e-06	0.00015	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	3.09e-06	0.000148	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	3.08e-06	0.000148	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	3.07e-06	0.000147	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	3.06e-06	0.000147	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—PPARA—atopic dermatitis	3.04e-06	0.000146	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	3.02e-06	0.000145	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	2.96e-06	0.000142	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NGF—atopic dermatitis	2.94e-06	0.000141	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	2.93e-06	0.000141	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	2.92e-06	0.000141	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NGF—atopic dermatitis	2.92e-06	0.00014	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	2.91e-06	0.00014	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	2.86e-06	0.000137	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	2.84e-06	0.000137	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	2.83e-06	0.000136	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—PPARA—atopic dermatitis	2.81e-06	0.000135	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	2.8e-06	0.000134	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	2.79e-06	0.000134	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	2.78e-06	0.000134	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CCL5—atopic dermatitis	2.78e-06	0.000134	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	2.78e-06	0.000134	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	2.78e-06	0.000134	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—NFKBIA—atopic dermatitis	2.78e-06	0.000134	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.78e-06	0.000133	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.77e-06	0.000133	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	2.76e-06	0.000133	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	2.74e-06	0.000132	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CCL5—atopic dermatitis	2.73e-06	0.000131	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	2.73e-06	0.000131	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	2.72e-06	0.000131	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	2.72e-06	0.000131	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	2.72e-06	0.000131	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	2.72e-06	0.000131	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	2.7e-06	0.00013	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	2.69e-06	0.000129	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	2.68e-06	0.000129	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	2.66e-06	0.000128	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	2.66e-06	0.000128	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	2.65e-06	0.000128	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	2.64e-06	0.000127	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	2.64e-06	0.000127	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	2.61e-06	0.000125	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	2.6e-06	0.000125	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NGF—atopic dermatitis	2.58e-06	0.000124	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	2.57e-06	0.000123	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NGF—atopic dermatitis	2.54e-06	0.000122	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NGF—atopic dermatitis	2.53e-06	0.000122	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	2.53e-06	0.000121	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NGF—atopic dermatitis	2.52e-06	0.000121	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	2.52e-06	0.000121	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NGF—atopic dermatitis	2.52e-06	0.000121	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	2.51e-06	0.000121	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CCR5—atopic dermatitis	2.51e-06	0.000121	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	2.5e-06	0.00012	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NGF—atopic dermatitis	2.49e-06	0.00012	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	2.48e-06	0.000119	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	2.48e-06	0.000119	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	2.47e-06	0.000119	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	2.47e-06	0.000119	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CCR5—atopic dermatitis	2.46e-06	0.000118	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	2.45e-06	0.000118	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL2—atopic dermatitis	2.45e-06	0.000118	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	2.45e-06	0.000118	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	2.42e-06	0.000117	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	2.42e-06	0.000116	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	2.42e-06	0.000116	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	2.41e-06	0.000116	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PPARA—atopic dermatitis	2.41e-06	0.000116	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	2.41e-06	0.000116	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL2—atopic dermatitis	2.41e-06	0.000116	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	2.4e-06	0.000115	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	2.39e-06	0.000115	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	2.37e-06	0.000114	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PPARA—atopic dermatitis	2.36e-06	0.000114	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	2.36e-06	0.000114	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CXCL8—atopic dermatitis	2.33e-06	0.000112	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CXCL8—atopic dermatitis	2.33e-06	0.000112	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	2.31e-06	0.000111	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL2—atopic dermatitis	2.23e-06	0.000107	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL2—atopic dermatitis	2.23e-06	0.000107	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—IL6—atopic dermatitis	2.22e-06	0.000107	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—IL6—atopic dermatitis	2.22e-06	0.000107	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	2.2e-06	0.000106	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	2.13e-06	0.000102	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	2.11e-06	0.000101	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL2—atopic dermatitis	2.1e-06	0.000101	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	2.09e-06	0.000101	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	2.09e-06	0.000101	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	2.09e-06	0.0001	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	2.08e-06	0.0001	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	2.07e-06	9.97e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	2.05e-06	9.88e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—MAPK8—atopic dermatitis	2.05e-06	9.87e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—MAPK8—atopic dermatitis	2.05e-06	9.86e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	2.05e-06	9.85e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL2—atopic dermatitis	2.01e-06	9.69e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	2e-06	9.64e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CXCL8—atopic dermatitis	1.98e-06	9.53e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	1.94e-06	9.31e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL2—atopic dermatitis	1.89e-06	9.11e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—IL6—atopic dermatitis	1.88e-06	9.06e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	1.85e-06	8.92e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PPARA—atopic dermatitis	1.82e-06	8.77e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PPARA—atopic dermatitis	1.78e-06	8.56e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MAPK8—atopic dermatitis	1.74e-06	8.38e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	1.73e-06	8.3e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	1.72e-06	8.26e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.68e-06	8.07e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL2—atopic dermatitis	1.65e-06	7.94e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	1.64e-06	7.91e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	1.64e-06	7.9e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL2—atopic dermatitis	1.64e-06	7.9e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	1.63e-06	7.86e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	1.57e-06	7.56e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	1.56e-06	7.52e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	1.52e-06	7.31e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	1.52e-06	7.29e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	1.51e-06	7.27e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	1.49e-06	7.17e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	1.49e-06	7.16e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	1.48e-06	7.14e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	1.48e-06	7.11e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	1.46e-06	7.04e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	1.46e-06	7.03e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL2—atopic dermatitis	1.45e-06	6.97e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	1.45e-06	6.96e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL6—atopic dermatitis	1.44e-06	6.93e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL2—atopic dermatitis	1.43e-06	6.86e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL2—atopic dermatitis	1.42e-06	6.84e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PPARA—atopic dermatitis	1.42e-06	6.83e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	1.42e-06	6.82e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL2—atopic dermatitis	1.42e-06	6.82e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL6—atopic dermatitis	1.42e-06	6.81e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL2—atopic dermatitis	1.41e-06	6.8e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	1.41e-06	6.79e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	1.41e-06	6.76e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL2—atopic dermatitis	1.4e-06	6.73e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	1.4e-06	6.71e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	1.39e-06	6.7e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	1.39e-06	6.68e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	1.33e-06	6.41e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	1.31e-06	6.31e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL6—atopic dermatitis	1.31e-06	6.3e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	1.31e-06	6.3e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL6—atopic dermatitis	1.31e-06	6.3e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	1.31e-06	6.28e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	1.3e-06	6.26e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	1.29e-06	6.2e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	1.29e-06	6.18e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL6—atopic dermatitis	1.24e-06	5.95e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL6—atopic dermatitis	1.18e-06	5.69e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL6—atopic dermatitis	1.11e-06	5.35e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.1e-06	5.27e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL6—atopic dermatitis	9.7e-07	4.67e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL6—atopic dermatitis	9.65e-07	4.64e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	9.24e-07	4.44e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL6—atopic dermatitis	8.52e-07	4.1e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL6—atopic dermatitis	8.38e-07	4.03e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL6—atopic dermatitis	8.36e-07	4.02e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL6—atopic dermatitis	8.34e-07	4.01e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL6—atopic dermatitis	8.31e-07	4e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL6—atopic dermatitis	8.23e-07	3.96e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	8.21e-07	3.95e-05	CbGpPWpGaD
